Medirom Healthcare Technologies, Inc. (MRM) has released an update.
MEDIROM Healthcare Technologies Inc. has announced its intention to acquire Japan Gene Medicine Corporation, aiming to expand its healthtech business and create synergies with its existing wellness brands. The strategic move is expected to enhance MEDIROM’s vision of offering comprehensive healthcare services and boost its corporate value. A memorandum of understanding has been signed with a definitive agreement targeted by May 31, 2024, and the acquisition process is set to be funded through cash and potential loans.
For further insights into MRM stock, check out TipRanks’ Stock Analysis page.
